Ocrelizumab is granted EU licence for PPMS and RRMS

Discuss Ocrelizumab, a monoclonal antibody treatment for MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

Ocrelizumab is granted EU licence for PPMS and RRMS

Post by MSUK » Fri Jan 12, 2018 5:51 am

Ocrelizumab is granted EU licence for primary progressive and relapsing remitting MS

The European Commission (EC) has granted a licence for the use of ocrelizumab, also known as Ocrevus, in people with primary progressive multiple sclerosis (PPMS) and relapsing remitting multiple sclerosis (RRMS)…Read more - http://www.ms-uk.org/ocrelizumab-grante ... mitting-ms

Image
MS-UK - http://www.ms-uk.org/
Top
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Ocrevus (Ocrelizumab)”